BillionToOneBLLN +2.04%13 FCF Margin % is 10.11% as of Mar. 2026. GuruFocus rates BLLN with a GF Score™ of 13/100. The stock has 5 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, BillionToOne ranks better than 69.95% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BillionToOne's Free Cash Flow for the
three
months ended in Mar. 2026 was $11.0 Mil. BillionToOne's Revenue for the
three
months ended in Mar. 2026 was $108.4 Mil. Therefore, BillionToOne's FCF Margin % for the quarter that ended in Mar. 2026 was 10.11%.
The historical rank and industry rank for BillionToOne's FCF Margin % or its related term are showing as below:
BLLN'
s FCF Margin % Range Over the Past 10 Years
Min: -84.81 Med: -30.68 Max: 7.43
Current: 7.43
During the past 3 years, the highest FCF Margin % of BillionToOne was 7.43%. The lowest was -84.81%. And the median was -30.68%.
BLLN's FCF Margin % is ranked better than 69.95% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.89
vs BLLN: 7.43
BillionToOne FCF Margin % Related Terms
BillionToOne FCF Margin % Historical Data
* Premium members only.
The historical data trend for BillionToOne's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, BillionToOne's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BillionToOne FCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, BillionToOne's FCF Margin % distribution charts can be found below:
* The bar in red indicates where BillionToOne's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BillionToOne (BLLN) has a FCF Margin % of 10.11% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BillionToOne and its competitors. According to the industry distribution chart, BillionToOne ranks #61 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 30%.
Is BillionToOne's FCF Margin % too high?
BillionToOne's current FCF Margin % is 10.11%. Based on the distribution chart, BillionToOne ranks #61 out of 203 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, BillionToOne has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does BillionToOne's FCF Margin % compare to SHC and VCYT?
According to the Medical Diagnostics & Research industry distribution chart, BillionToOne ranks #61 out of 203 companies for FCF Margin %. This puts BillionToOne in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BillionToOne and its competitors. BillionToOne's current FCF Margin % is 10.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BillionToOne stock overvalued right now?
BillionToOne (BLLN) has a current FCF Margin % of 10.11%. The current FCF Margin % is 10.11%. BillionToOne's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For BillionToOne (BLLN), the current FCF Margin % is 10.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
13GF Score
Get the complete analysis for BLLN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLLN has been successfully added to your 